Research Advances

The cowpea mosaic virus (CPMV), a harmless plant virus that infects black-eyed peas, is emerging as a novel cancer immunotherapy. Rather than killing tumor cells directly, CPMV activates the immune system, turning the tumor microenvironment from immunosuppressive into highly inflammatory and responsive to attack. When injected into tumors, CPMV acts as a strong “danger signal,” […]

Tumor-infiltrating lymphocyte (TIL) therapy is a personalized immunotherapy that uses a patient’s own immune cells to fight cancer. T cells are collected from a tumor, expanded in the lab using growth factors like Interleukin-2, and reinfused after lymphodepleting chemotherapy, followed by additional IL-2 support to boost activity. This approach is promising for non-small cell lung